DJIA, S&P Up; Nasdaq Down on Big Earnings Misses

Jacob Harper |

Tech got hammered in Wednesday action and sent the tech-heavy Nasdaq southward on the Wednesday trading day while the DJIA and the S&P 500 both rose as investors fled growth plays in favor of blue chips.

The biggest hit for tech came from daily deals site Groupon (GRPN) , who issued poor earnings and consequently plummeted 22.77 percent. NYSE-listed Twitter (TWTR) continued reeling from the expiration of its internal share lockup the day prior, as shares went an additional 3.94 percent lower as the sell-off continued to worsen, helping drag the entire tech sector down and Nasdaq with it. Facebook (FB) followed the trend, losing 2.14 percent on the day.

Solar was hit hard as well, with First Solar (FSLR) quizzically dropping despite beating earnings. The majority of the solar sector followed suit.

It’s wasn’t all rainy days on the market. Dow components United Health (UNH) and American Express (AXP) saw gains of 3.52 percent and 2.06 percent, respectively. In the S&P 500 Electronic Arts (EA) was the clear winner, gaining 21.03 percent after crushing earnings expectations.   

Results for May 7, 2014

  • Standard & Poor’s 500: +.55 percent to 1,878 points
  • Dow Jones Industrial Average: +.72 percent to 16,519 points
  • NASDAQ Exchange:  -0.31 percent to 4,068 points

Our Top Stories


DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
CORT Corcept Therapeutics Incorporated 7.01 0.07 1.01 408,096
EA Electronic Arts Inc. 84.15 1.28 1.54 3,046,700
GCA null n/a n/a n/a 0
GRPN Groupon Inc. 5.17 0.15 2.99 4,699,338
NOVZ Novagen Ingenium Inc 0.12 0.00 0.00 0
QTWW Quantum Fuel Systems Technologies Worldwide Inc. n/a n/a n/a 0
SCTY SolarCity Corporation 19.95 -0.04 -0.20 3,657,342


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…


Uber connects riders with safe, reliable, convenient transportation providers at a variety of price-points in cities around the world. Uber makes money from charging their drivers 20% of the fare…